Medication Assisted Therapy

Using Buprenorphine for opioid use disorders

Target Audience

Physicians

Advanced Practice Clinicians

Learning Objectives

  • Examine and be able to describe different types of pain and factors that contribute to and exacerbate pain.
  • Optimize evidence based non-pharmacological and non-opioid chronic pain management for patients with chronic pain.
  • Improve use of clinical communication tools around chronic opioid therapy such as controlled substance agreements, informed consent and communication of specific risk.
  • Implement evidence based opioid stewardship practices including screening and monitoring for unintended medication harms and be able to optimize medication safety.
  • Be able to recognize overdose risks and unsafe medication combinations. Be able to counsel on overdose prevention and optimize provision of naloxone for patients on chronic opioid therapy.
  • Be able to recognize opioid use disorders and be knowledgeable on treatment with buprenorphine and Medications for Addiction Treatment.
  • Improve interpersonal communication skills for patient communication including skills such as motivational interviewing and de-escalation.
  • Effectively document and communicate treatment plans to patients and in the medical record.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
Course opens: 
11/04/2025
Course expires: 
11/04/2028
Part of: 
Compass Opioid Stewardship Certificate Program
Rating: 
0

Joshua Blum, MD

Dr. Blum is the Program Manager of the Denver Health HIV Primary Care Clinic, a Ryan White-funded
clinic serving low income clients living with HIV/AIDS. He also provides HIV and general primary care to
patients in the Denver City and County jails, and medication-assisted treatment to patients with opioid
use disorders in Denver Health’s outpatient behavioral health services department.

He established and served as the first physician manager of the Intensive Outpatient Clinic, a high
intensity primary care clinic aimed at caring for Denver Health’s sickest and highest-utilizing patients. Dr.
Blum is an institutional quality officer and leads initiatives on pain and opioid management at Denver
Health, and currently oversees a federal grant for expanding medication-assisted treatment in the
Denver Health primary care clinics. He is the co-chair of the Provider Education Workgroup at the
Colorado Consortium for Prescription Drug Abuse Prevention.

As a general internist caring for high-risk populations, his interests include the diagnosis and treatment
of HIV and Hepatitis C, chronic pain syndromes, opioid management, mental health, and substance
abuse. He is a frequent speaker on pain management, opioids, and substance abuse.

Continuing Medical Education (CME)

Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Compass Healthcare Collaborative is accredited by the IMS to provide continuing medical education for physicians. 

Designation: Compass designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Commercial Support: This activity was developed without support from any ineligible company. *The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company. 

Disclosure: Compass adheres to the Standards for Integrity and Independence in Accredited Continuing Education. The content of this activity is not related to products or the business lines of an ACCME-defined ineligible company. None of the planners or moderators for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or on patients.

Note: AMA PRA Category 1 Credits™ are accepted for nursing and other healthcare discipline license renewal purposes, provided the topic is relevant to the applicant’s field or discipline. After participating, you will receive a Certificate of Attendance detailing the number of AMA PRA Category 1 Credits™ you can claim. This certificate is provided for self-reporting requirements and must be submitted to your state board for license renewal.

Merit-based Incentive Payment System (MIPS) Credit Designation: Improvement Activity (IA): This activity qualifies for MIPS credit as an Improvement Activity. Participants who successfully completed the activity are eligible for full credit for the Improvement Activities category of the MIPS program. Note: Each provider must attest to your participation and practice changes on the CMS QPP website, but you can reference the MIPS verbiage noted below. 

Activity Type: Patient Safety and Practice Assessment (IA_PSPA_CME): 

Activity ID: IA_PSPA_28: Completion of an Accredited Safety or Quality Improvement Program.

  • Documentation includes:
    • Meaningful clinician participation in a project focused on improving pain management.
    • Documentation of data collection and analysis regarding prescribing patterns.
    • Implementation of interventions to improve quality or safety.
    • Measurement of the impact of the interventions. 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
Please login or register to take this course.

You are registering to take a live recorded webinar course.